USA Today

Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of ...

FOR IMMEDIATE RELEASE – Nov. 6,2025 – LAKE ZURICH, Ill.— Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies is ...
Yahoo

Hospital Acid Reflux Drug Recalled: Endotoxins Risk Sepsis, Shock

Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2mL fill in a 2 mL vial recall Image by FDApress release A widely used hospital drug for treating severe acid reflux is being recalled over ...
Business Wire

FRESENIUS KABI ISSUES VOLUNTARY NATIONWIDE RECALL OF THREE LOTS OF FAMOTIDINE INJECTION, USP, 20 MG PER 2 ML (10 MG PER ML), 2 ML FILL IN A 2 ML VIAL DUE TO OUT ...

Famotidine Injection is indicated in some hospitalized patients with pathological hypersecretory conditions or intractable ulcers, or as an alternative to the oral dosage forms for short term use in ...
The Bakersfield Californian

Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of ...

Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies is voluntarily recalling three lots (numbers 6133156, 6133194, ...
Eagle-Tribune

CORRECTING and REPLACING Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial ...

In the table of the release dated Nov 6, 2025, First Ship Date for Batch Number 6133388 should be 04/15/2025.